2021 NJPN Conference Program Book

Emerging Use of Genetics in Successfully Preventing & Treating Opioid Use Disorders DONALD PARKER President | Hackensack Meridian Health - Carrier Clinic

Clinicians understand there is a genetic link to the development of Substance Use Disorders in that family history is present in upwards of 60% of those treated, even when ruling our environmental factors. Medical studies are increasingly able to identify genetic markers that indicate greater susceptibility to development of SUD’s. Increasingly, protocols are being developed to identify and target (through genetic testing) the unique ‘gene sequence’ of an individual in order to treat the identifiers associated with higher risk of developing SUD’s, thus mitigating the significant genetic risk factors. This workshop will explore: Challenges related to the battle against opiate misuse, the opiate epidemic, and treatment protocols for opiate use disorders; he latest industry practices, including research into the role of genetics in preventing and treating Opiate Use Disorders; and Emerging urgent care services in addiction and behavioral health.

24